- 24/7 Wall St.•19 hours ago
Major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco, but now a key research firm is seeing one of these companies in a positive light.
- Benzinga•21 hours ago
AstraZeneca plc (ADR) (NYSE: AZN ) shares are currently trading at a discount to S&P 500 pharma companies. Argus’ John Eade believes the discount is too steep given the company’s pipeline potential. Eade ...
AstraZeneca PLC (AZN)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||33.10 x 1000|
|Ask||33.13 x 400|
|Day's Range||33.05 - 33.42|
|52wk Range||26.97 - 35.04|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||38.06|
|Avg Vol (3m)||6,104,518|
|Dividend & Yield||0.90 (2.72%)|